Immunoglobulin G4-related sclerosing cholangitis

키워드

참고문헌 (61)

1. Deshpande V, "Consensus statement on the pathology of IgG4-related disease", Mod Pathol, 25, pp.1181~1192 (2012)[DOI]
2. Brito-Zeron P, "The clinical spectrum of IgG4-related disease", Autoimmun Rev, 13, pp.1203~1210 (2014)[DOI]
3. Kawa S, "Current concepts and diagnosis of IgG4-related pancreatitis (type 1 AIP)", Semin Liver Dis, 36, pp.257~273 (2016)[DOI]
4. Ghazale A, "Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy", Gastroenterology, 134, pp.706~715 (2008)[DOI]
5. Culver EL, "IgG4-related hepatobiliary disease: an overview", Nat Rev Gastroenterol Hepatol, 13, pp.601~612 (2016)[DOI]
6. Okazaki K, "Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease", J Gastroenterol, 46, pp.277~288 (2011)[DOI]
7. Bozzalla Cassione E, "IgG4-related disease", Curr Opin Rheumatol, 29, pp.223~227 (2017)[DOI]
8. Della Torre E, "IgG4-related pachymeningitis: evidence of intrathecal IgG4 on cerebrospinal fluid analysis", Ann Intern Med, 156, pp.401~403 (2012)
9. Mattoo H, "De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease", J Allergy Clin Immunol, 134, pp.679~687 (2014)[DOI]
10. Trampert DC, "On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease", Biochim Biophys Acta, 1864(4), pp.1401~1409 (2018)[DOI]
11. Mattoo H, "Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease", J Allergy Clin Immunol, 138, pp.825~838 (2016)[DOI]
12. Akiyama M, "Number of circulating follicular helper 2 T cells correlates with IgG4 and interleukin-4 levels and plasmablast numbers in IgG4-related disease", Arthritis Rheumatol, 67, pp.2476~2481 (2015)[DOI]
13. Akiyama M, "Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease", Arthritis Res Ther, 18, pp.167~ (2016)[DOI]
14. Gerli R, "CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients", Circulation, 109, pp.2744~2748 (2004)[DOI]
15. Wolfson AR, "Recent advances in understanding and managing IgG4-related disease", F1000Res, 6, pp.185~ (2017)[DOI]
16. Masamune A, "Nationwide epidemiological survey of early chronic pancreatitis in Japan", J Gastroenterol, 52, pp.992~1000 (2017)[DOI]
17. Chari ST, "Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience", Clin Gastroenterol Hepatol, 4, pp.1010~1016 (2006)[DOI]
18. Huggett MT, "Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort", Am J Gastroenterol, 109, pp.1675~1683 (2014)[DOI]
19. Oseini AM, "Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma", Hepatology, 54, pp.940~948 (2011)[DOI]
20. Boonstra K, "Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis", Hepatology, 59, pp.1954~1963 (2014)[DOI]
21. Mendes FD, "Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis", Am J Gastroenterol, 101, pp.2070~2075 (2006)[DOI]
22. Culver EL, "Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort", Am J Gastroenterol, 111, pp.733~743 (2016)[DOI]
23. Cheuk W, "Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity", Semin Diagn Pathol, 29, pp.226~234 (2012)[DOI]
24. Strehl JD, "Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders", J Clin Pathol, 64, pp.237~243 (2011)[DOI]
25. Zhang J, "Characterizing IgG4-related disease with 18F-FDG PET", CT: a prospective cohort study, 2014, pp.41, 1624~1634
26. Masamune A, "Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis", Gut, 66, pp.487~494 (2017)[DOI]
27. Sandanayake NS, "Presentation and management of post-treatment relapse in autoimmune pancreatitis", immunoglobulin G4-associated cholangitis, 2009, pp.7, 1089~1096
28. Kamisawa T, "IgG4-related disease", Lancet, 385, pp.1460~1471 (2015)[DOI]
29. Ebbo M, "Long-term efficacy and safety of rituximab in IgG4-related disease: data from a French nationwide study of thirty-three patients", PLoS One, 12, pp.e0183844~ (2017)[DOI]
30. Hart PA, "Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience", Gut, 62, pp.1607~1615 (2013)[DOI]
31. Carruthers MN, "Rituximab for IgG4-related disease: a prospective, open-label trial", Ann Rheum Dis, 74, pp.1171~1177 (2015)
32. Brito-Zeron P, "Therapeutic approach to IgG4-related disease: a systematic review", Medicine (Baltimore), 95, pp.e4002~ (2016)[DOI]
33. Sah RP, "Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis", Gastroenterology, 139, pp.140~148 (2010)[DOI]
34. Ahn SS, "Malignancies in Korean patients with immunoglobulin G4-related disease", Int J Rheum Dis, 20, pp.1028~1035 (2017)[DOI]
35. Okazaki K, "Recent concepts of autoimmune pancreatitis and IgG4-related disease", Clin Rev Allergy Immunol, 41, pp.126~138 (2011)[DOI]
36. Ohara H, "Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012", J Hepatobiliary Pancreat Sci, 19, pp.536~542 (2012)[DOI]
37. Tanaka A, "Clinical features, response to treatment, and outcomes of IgG4-related sclerosing cholangitis", Clin Gastroenterol Hepatol, 15, pp.920~926 (2017)[DOI]
38. Oh HC, "Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma", J Gastroenterol Hepatol, 25, pp.1831~1837 (2010)[DOI]
39. Yata M, "Comparison of the multidetector-row computed tomography findings of IgG4-related sclerosing cholangitis and extrahepatic cholangiocarcinoma", Clin Radiol, 71, pp.203~210 (2016)[DOI]
40. Nakazawa T, "Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography", Pancreas, 32, pp.229~ (2006)[DOI]
41. Kanno A, "Endoscopic approaches for the diagnosis of autoimmune pancreatitis", Dig Endosc, 27, pp.250~258 (2015)[DOI]
42. Shimizu S, "IgG4-related sclerosing cholangitis with no biliary stricture but severe thickening of the bile duct wall", Intern Med, 55, pp.1575~1579 (2016)[DOI]
43. Naitoh I, "Predictive factors for positive diagnosis of malignant biliary strictures by transpapillary brush cytology and forceps biopsy", J Dig Dis, 17, pp.44~51 (2016)[DOI]
44. Kubota K, "Differentiating sclerosing cholangitis caused by autoimmune pancreatitis and primary sclerosing cholangitis according to endoscopic duodenal papillary features", Gastrointest Endosc, 68, pp.1204~1208 (2008)[DOI]
45. Okano N, "Case of immunoglobulin G4-related cholangitis accompanying autoimmune pancreatitis: diagnosis by peroral cholangioscopy and treatment by endoscopic biliary stenting", Dig Endosc, 24(Suppl 1), pp.62~66 (2012)[DOI]
46. Bi Y, "Obstructive jaundice in autoimmune pancreatitis can be safely treated with corticosteroids alone without biliary stenting", Pancreatology, 16, pp.391~396 (2016)[DOI]
47. Arora Z, "Comment re: "Obstructive jaundice in autoimmune pancreatitis can be safely treated with corticosteroids alone without biliary stenting"", Pancreatology, 16, pp.689~690 (2016)[DOI]
48. Kalaitzakis E, "Endoscopic diagnosis of biliary tract disease", Curr Opin Gastroenterol, 28, pp.273~279 (2012)[DOI]
49. Kalaitzakis E, "Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma", Clin Gastroenterol Hepatol, 9, pp.800~803 (2011)[DOI]
50. Joshi D, "Biliary and hepatic involvement in IgG4-related disease", Aliment Pharmacol Ther, 40, pp.1251~1261 (2014)[DOI]
51. Erdogan D, "Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures", Br J Surg, 95, pp.727~734 (2008)[DOI]
52. Taku Tabata, "Differentiating Immunoglobulin G4-Related Sclerosing Cholangitis from Hilar Cholangiocarcinoma", Gut and Liver, 7(2), pp.234~238 (2013), 거트앤리버 소화기연관학회협의회
53. Hamano H, "Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis?", Gastrointest Endosc, 62, pp.152~157 (2005)[DOI]
54. Ramchandani M, "Role of single-operator peroral cholangioscopy in the diagnosis of indeterminate biliary lesions: a single-center, prospective study", Gastrointest Endosc, 74, pp.511~519 (2011)[DOI]
55. Navaneethan U, "Digital, single-operator cholangiopancreatoscopy in the diagnosis and management of pancreatobiliary disorders: a multicenter clinical experience (with video)", Gastrointest Endosc, 84, pp.649~655 (2016)[DOI]
56. Navaneethan U, "Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review", Gastrointest Endosc, 82, pp.608~614 (2015)[DOI]
57. Hirano K, "Involvement of the biliary system in autoimmune pancreatitis: a follow-up study", Clin Gastroenterol Hepatol, 1, pp.453~464 (2003)[DOI]
58. Straub BK, "IgG4-associated cholangitis with cholangiocarcinoma", Virchows Arch, 458, pp.761~765 (2011)[DOI]
59. Khosroshahi A, "International consensus guidance statement on the management and treatment of IgG4-related disease", Arthritis Rheumatol, 67, pp.1688~1699 (2015)[DOI]
60. Kamisawa T, "Standard steroid treatment for autoimmune pancreatitis", Gut, 58, pp.1504~1507 (2009)[DOI]
61. Hart PA, "Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis", Gut, 62, pp.1771~1776 (2013)[DOI]

관련 논문AI추천